X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA AJANTA PHARMA SHASUN PHARMA/
AJANTA PHARMA
 
P/E (TTM) x 123.9 21.1 586.6% View Chart
P/BV x 8.5 9.1 93.4% View Chart
Dividend Yield % 0.2 0.7 35.5%  

Financials

 SHASUN PHARMA   AJANTA PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
AJANTA PHARMA
Mar-16
SHASUN PHARMA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs941,720 5.5%   
Low Rs461,103 4.1%   
Sales per share (Unadj.) Rs214.2194.6 110.1%  
Earnings per share (Unadj.) Rs5.345.2 11.8%  
Cash flow per share (Unadj.) Rs15.850.3 31.5%  
Dividends per share (Unadj.) Rs1.008.00 12.5%  
Dividend yield (eoy) %1.40.6 252.4%  
Book value per share (Unadj.) Rs53.3132.0 40.4%  
Shares outstanding (eoy) m56.6288.77 63.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.37.3 4.5%   
Avg P/E ratio x13.131.2 42.0%  
P/CF ratio (eoy) x4.428.1 15.7%  
Price / Book Value ratio x1.310.7 12.3%  
Dividend payout %18.717.7 105.9%   
Avg Mkt Cap Rs m3,958125,299 3.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1642,570 84.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,12717,275 70.2%  
Other income Rs m229166 137.9%   
Total revenues Rs m12,35617,442 70.8%   
Gross profit Rs m1,0095,807 17.4%  
Depreciation Rs m594451 131.7%   
Interest Rs m41549 848.9%   
Profit before tax Rs m2305,474 4.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-731,460 -5.0%   
Profit after tax Rs m3024,014 7.5%  
Gross profit margin %8.333.6 24.8%  
Effective tax rate %-31.726.7 -118.7%   
Net profit margin %2.523.2 10.7%  
BALANCE SHEET DATA
Current assets Rs m6,8847,639 90.1%   
Current liabilities Rs m8,4562,715 311.5%   
Net working cap to sales %-13.028.5 -45.5%  
Current ratio x0.82.8 28.9%  
Inventory Days Days6243 142.6%  
Debtors Days Days10879 136.7%  
Net fixed assets Rs m4,9706,914 71.9%   
Share capital Rs m113177 64.0%   
"Free" reserves Rs m2,87511,442 25.1%   
Net worth Rs m3,02011,721 25.8%   
Long term debt Rs m1,817149 1,222.2%   
Total assets Rs m13,34714,814 90.1%  
Interest coverage x1.6112.9 1.4%   
Debt to equity ratio x0.60 4,743.0%  
Sales to assets ratio x0.91.2 77.9%   
Return on assets %5.427.4 19.6%  
Return on equity %10.034.2 29.2%  
Return on capital %13.346.5 28.6%  
Exports to sales %46.455.1 84.1%   
Imports to sales %14.26.0 237.2%   
Exports (fob) Rs m5,6229,527 59.0%   
Imports (cif) Rs m1,7281,038 166.5%   
Fx inflow Rs m5,84310,422 56.1%   
Fx outflow Rs m2,1731,678 129.5%   
Net fx Rs m3,6698,744 42.0%   
CASH FLOW
From Operations Rs m3983,264 12.2%  
From Investments Rs m-1,635-2,093 78.1%  
From Financial Activity Rs m1,309-1,186 -110.4%  
Net Cashflow Rs m71-15 -481.1%  

Share Holding

Indian Promoters % 39.2 73.8 53.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 1.6 232.3%  
FIIs % 17.6 7.6 231.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 17.0 232.9%  
Shareholders   20,750 20,968 99.0%  
Pledged promoter(s) holding % 12.3 4.4 280.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  WYETH LTD  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bank Stocks Witness Selling(01:30 pm)

After opening the day on a flat note, the Indian share markets have reversed the trend and are currently trading above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS